A Dominant Negative Mutant of an IFN Regulatory Factor Family Protein Inhibits Both Type I and Type II IFN-Stimulated Gene Expression and Antiproliferative Activity of IFNs

Angela M. Thornton, Vasily V. Ogryzko, Alexander Dent, Rakefet Sharf, Ben Zion Levi, Yuka Kanno, Louis M. Staudt, Bruce H. Howard, Keiko Ozato

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Type I (α,β) and type II (γ) IFNs elicit antiproliferative and antiviral activities through two distinct transcription pathways involving 1) IRF family proteins and ISGF3, and 2) STAT1. We have employed a dominant negative strategy to study the role of IRF family proteins in eliciting the biologic activities of IFN. A truncated IRF protein retaining the DNA-binding domain (DBD) of ICSBP (a member of the IRF family) was stably transfected into U937 monocytic cells. Clones expressing DBD had markedly reduced ISRE-binding activity and were defective in expressing several type I IFN-inducible genes. STAT1 was one such type I IFN-inducible gene whose expression was also inhibited in DBD clones. As a result, the expression of several IFN-γ-inducible genes was also inhibited in these clones, indicating functional coupling of the type I and type II IFN transcription pathways. Furthermore, DBD clones grew more slowly than control clones and were refractory to antiproliferative effects of both types of IFNs. We found that IFN treatment of U937 cells leads to a G1 arrest and an increase in underphosphorylated retinoblastoma gene product. However, IFN treatment did not change the cell cycle profile, nor retinoblastoma gene product phosphorylation state in DBD clones. These data indicate that expression of DBD disrupts cell cycle regulatory mechanisms. Combined with the previously noted failure of DBD clones to elicit antiviral activity, the present work shows that IRF family proteins play an integral part in growth control activities of IFNs.

Original languageEnglish (US)
Pages (from-to)5145-5154
Number of pages10
JournalJournal of Immunology
Volume157
Issue number11
StatePublished - Dec 1 1996
Externally publishedYes

Fingerprint

Clone Cells
Gene Expression
DNA
Proteins
Retinoblastoma Genes
U937 Cells
Antiviral Agents
Cell Cycle
Interferon Regulatory Factor-1
DNA-Binding Proteins
Genes
Phosphorylation
Growth

ASJC Scopus subject areas

  • Immunology

Cite this

A Dominant Negative Mutant of an IFN Regulatory Factor Family Protein Inhibits Both Type I and Type II IFN-Stimulated Gene Expression and Antiproliferative Activity of IFNs. / Thornton, Angela M.; Ogryzko, Vasily V.; Dent, Alexander; Sharf, Rakefet; Levi, Ben Zion; Kanno, Yuka; Staudt, Louis M.; Howard, Bruce H.; Ozato, Keiko.

In: Journal of Immunology, Vol. 157, No. 11, 01.12.1996, p. 5145-5154.

Research output: Contribution to journalArticle

Thornton, AM, Ogryzko, VV, Dent, A, Sharf, R, Levi, BZ, Kanno, Y, Staudt, LM, Howard, BH & Ozato, K 1996, 'A Dominant Negative Mutant of an IFN Regulatory Factor Family Protein Inhibits Both Type I and Type II IFN-Stimulated Gene Expression and Antiproliferative Activity of IFNs', Journal of Immunology, vol. 157, no. 11, pp. 5145-5154.
Thornton, Angela M. ; Ogryzko, Vasily V. ; Dent, Alexander ; Sharf, Rakefet ; Levi, Ben Zion ; Kanno, Yuka ; Staudt, Louis M. ; Howard, Bruce H. ; Ozato, Keiko. / A Dominant Negative Mutant of an IFN Regulatory Factor Family Protein Inhibits Both Type I and Type II IFN-Stimulated Gene Expression and Antiproliferative Activity of IFNs. In: Journal of Immunology. 1996 ; Vol. 157, No. 11. pp. 5145-5154.
@article{92778eccae6647288116d4a78d8218a4,
title = "A Dominant Negative Mutant of an IFN Regulatory Factor Family Protein Inhibits Both Type I and Type II IFN-Stimulated Gene Expression and Antiproliferative Activity of IFNs",
abstract = "Type I (α,β) and type II (γ) IFNs elicit antiproliferative and antiviral activities through two distinct transcription pathways involving 1) IRF family proteins and ISGF3, and 2) STAT1. We have employed a dominant negative strategy to study the role of IRF family proteins in eliciting the biologic activities of IFN. A truncated IRF protein retaining the DNA-binding domain (DBD) of ICSBP (a member of the IRF family) was stably transfected into U937 monocytic cells. Clones expressing DBD had markedly reduced ISRE-binding activity and were defective in expressing several type I IFN-inducible genes. STAT1 was one such type I IFN-inducible gene whose expression was also inhibited in DBD clones. As a result, the expression of several IFN-γ-inducible genes was also inhibited in these clones, indicating functional coupling of the type I and type II IFN transcription pathways. Furthermore, DBD clones grew more slowly than control clones and were refractory to antiproliferative effects of both types of IFNs. We found that IFN treatment of U937 cells leads to a G1 arrest and an increase in underphosphorylated retinoblastoma gene product. However, IFN treatment did not change the cell cycle profile, nor retinoblastoma gene product phosphorylation state in DBD clones. These data indicate that expression of DBD disrupts cell cycle regulatory mechanisms. Combined with the previously noted failure of DBD clones to elicit antiviral activity, the present work shows that IRF family proteins play an integral part in growth control activities of IFNs.",
author = "Thornton, {Angela M.} and Ogryzko, {Vasily V.} and Alexander Dent and Rakefet Sharf and Levi, {Ben Zion} and Yuka Kanno and Staudt, {Louis M.} and Howard, {Bruce H.} and Keiko Ozato",
year = "1996",
month = "12",
day = "1",
language = "English (US)",
volume = "157",
pages = "5145--5154",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "11",

}

TY - JOUR

T1 - A Dominant Negative Mutant of an IFN Regulatory Factor Family Protein Inhibits Both Type I and Type II IFN-Stimulated Gene Expression and Antiproliferative Activity of IFNs

AU - Thornton, Angela M.

AU - Ogryzko, Vasily V.

AU - Dent, Alexander

AU - Sharf, Rakefet

AU - Levi, Ben Zion

AU - Kanno, Yuka

AU - Staudt, Louis M.

AU - Howard, Bruce H.

AU - Ozato, Keiko

PY - 1996/12/1

Y1 - 1996/12/1

N2 - Type I (α,β) and type II (γ) IFNs elicit antiproliferative and antiviral activities through two distinct transcription pathways involving 1) IRF family proteins and ISGF3, and 2) STAT1. We have employed a dominant negative strategy to study the role of IRF family proteins in eliciting the biologic activities of IFN. A truncated IRF protein retaining the DNA-binding domain (DBD) of ICSBP (a member of the IRF family) was stably transfected into U937 monocytic cells. Clones expressing DBD had markedly reduced ISRE-binding activity and were defective in expressing several type I IFN-inducible genes. STAT1 was one such type I IFN-inducible gene whose expression was also inhibited in DBD clones. As a result, the expression of several IFN-γ-inducible genes was also inhibited in these clones, indicating functional coupling of the type I and type II IFN transcription pathways. Furthermore, DBD clones grew more slowly than control clones and were refractory to antiproliferative effects of both types of IFNs. We found that IFN treatment of U937 cells leads to a G1 arrest and an increase in underphosphorylated retinoblastoma gene product. However, IFN treatment did not change the cell cycle profile, nor retinoblastoma gene product phosphorylation state in DBD clones. These data indicate that expression of DBD disrupts cell cycle regulatory mechanisms. Combined with the previously noted failure of DBD clones to elicit antiviral activity, the present work shows that IRF family proteins play an integral part in growth control activities of IFNs.

AB - Type I (α,β) and type II (γ) IFNs elicit antiproliferative and antiviral activities through two distinct transcription pathways involving 1) IRF family proteins and ISGF3, and 2) STAT1. We have employed a dominant negative strategy to study the role of IRF family proteins in eliciting the biologic activities of IFN. A truncated IRF protein retaining the DNA-binding domain (DBD) of ICSBP (a member of the IRF family) was stably transfected into U937 monocytic cells. Clones expressing DBD had markedly reduced ISRE-binding activity and were defective in expressing several type I IFN-inducible genes. STAT1 was one such type I IFN-inducible gene whose expression was also inhibited in DBD clones. As a result, the expression of several IFN-γ-inducible genes was also inhibited in these clones, indicating functional coupling of the type I and type II IFN transcription pathways. Furthermore, DBD clones grew more slowly than control clones and were refractory to antiproliferative effects of both types of IFNs. We found that IFN treatment of U937 cells leads to a G1 arrest and an increase in underphosphorylated retinoblastoma gene product. However, IFN treatment did not change the cell cycle profile, nor retinoblastoma gene product phosphorylation state in DBD clones. These data indicate that expression of DBD disrupts cell cycle regulatory mechanisms. Combined with the previously noted failure of DBD clones to elicit antiviral activity, the present work shows that IRF family proteins play an integral part in growth control activities of IFNs.

UR - http://www.scopus.com/inward/record.url?scp=0030444053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030444053&partnerID=8YFLogxK

M3 - Article

C2 - 8943426

AN - SCOPUS:0030444053

VL - 157

SP - 5145

EP - 5154

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 11

ER -